LUNG (LUNG)

Financial Metrics & Valuation Analysis

Enterprise Valuation (TTM)

Enterprise Value$69.21M
EV / Sales0.79
EV / EBITDA-1.61
EV / Operating Cash Flow-2.73
EV / Free Cash Flow-2.72

Return Metrics (TTM)

Return on Equity (ROE)-96.66%
Return on Assets (ROA)-41.94%
Return on Invested Capital (ROIC)-48.39%
Return on Capital Employed (ROCE)-49.09%

Yield Metrics

Earnings Yield-69.98%
Free Cash Flow Yield-36.97%

Balance Sheet Strength

Net Debt / EBITDA-0.01
Current Ratio4.32
Working Capital$67.73M
Tangible Asset Value$36.86M
Net Current Asset Value$12.60M

Working Capital Efficiency

Days Sales Outstanding51.12
Days Payables Outstanding85.05
Operating Cycle (Days)349.30
Cash Conversion Cycle264.25

Capital Allocation

CapEx / Revenue0.13%
CapEx / Operating Cash Flow-0.44%
R&D / Revenue22.14%
SG&A / Revenue107.87%

Fiscal Year 2025 Ratios

Audited annual results as of 2025-12-31

Margins

Gross Profit Margin74.19%
Operating Margin-59.30%
Net Profit Margin-59.67%

Solvency

Debt / Equity1.04
Quick Ratio4.28
Cash Ratio3.49

Per Share

Revenue / Share$2.22
FCF / Share-$0.81
PE Ratio-1.66